Report Details

According to the report published by the Market Research Store, global demand for the gene delivery technologies market was estimated at approximately USD 2,610.8 Million in 2020 and is expected to generate revenue of around USD 4,400.7 Million by the end of 2026, growing at a CAGR of around 15.3% between 2021 and 2026.

Global Gene Delivery Technologies Market: Overview

Gene therapy is defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate use to prevent or alter a specific disease state. The genes and DNA are now being brought in without making use of vectors, and different techniques are being utilized in modifying the function of genes in vivo with no gene transfer. The extent of gene therapy becomes wider, if one adds to this cell therapy, mainly with the use of genetically modified cells. The gene therapy be able to now combined with antisense techniques like RNA interference (RNAi), increasing the therapeutic functions. 

Global Gene Delivery Technologies Market: Growth Factor

The global gene delivery technologies market is driven by key factors such as the rising prevalence of chronic diseases, the growing demand for targeted therapies and the rising technological advancements. Besides, other factors expected to stimulate the global market of gene delivery system is the augment in requirement for advanced technologies for targeted systems. Moreover, the launching of innovative and advanced technologies, the increase in demand for self-administration devices for home health care, the growing demand for targeted and the little dose frequency drug delivery, the growth in investment in research and development, and the increase in occurrence of chronic life-threatening diseases are some aspects likely to fuel the global gene delivery technologies market.

REPORT SNAPSHOT & REPORTING DATA TIMEFRAME
Parameter Details
Historical Date ( Actual Data) 2016 - 2020
Base Year Data 2020
Current Year Data 2021
Projected Data 2021 - 2026
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered product type, application, region
Regional scope North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
Country Scope U.S.; Canada; Mexico; Germany; France; U.K.; China; Japan; South Korea; Singapore; Malaysia; Brazil; Saudi Arabia
Customization scope Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs. Explore purchase options

However, the high expenses of the treatment along with the augment in drug recalls owing to severe regulations in rising countries might slow down the growth of the market.

Global Gene Delivery Technologies Market: Segmentation

The global gene delivery technologies market has been segmented into delivery systems, application, and route of administration. On the basis of delivery systems, the global gene delivery technologies market has been classified into viral gene delivery systems, non-viral gene delivery systems, and combined hybrid delivery systems. Based on the application, the global gene delivery technologies market has been categorized into oncology, infectious diseases, pulmonary disorders, cardiovascular disorders, diabetes, and others. In terms of route of administration, the global gene delivery technologies market has been divided into oral, injectable, nasal, and others.

Global Gene Delivery Technologies Market: Regional Analysis

The global gene delivery technologies market has been classified into North America, Europe, Asia-Pacific, Latin America, and the Middle East, and Africa. Globally, North America is leading the global gene delivery system market. North America and Europe together is contributing for significant share of the market, owing to the increase in occurrence of chronic diseases in the United States and Europe and the technological development in drug delivery technologies in this region. The augment in dominance of acute and chronic diseases in the United States is driving the demand for drug delivery systems in the region. The demand for drug and gene delivery system is mounting in this region due to augment in incidence of numerous chronic diseases. Moreover, the Asia Pacific market is anticipated to develop at a rapid rate in the global gene delivery technologies market owing to the boost in prevalence of diseases and the growing investment of major players in the region. Also, the market in the Middle East and Africa is expected to enlarge at a lethargic rate.

Global Gene Delivery Technologies Market: Competitive Players

The foremost market players driving in the global market of gene delivery technologies cover Novartis International AG, Horizon Discovery Group Co., Amgen Inc., QIAGEN, Oxford BioMedia plc, SignaGen Laboratories, SIBIONO, Hoffmann-La Roche AG, Shanghai Sunway Biotech Co. Ltd., Vectalys, Pfizer Inc., Sirion-Biotech GmbH, Bayer AG, Takara Bio Inc., Johnson & Johnson Services Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., System Biosciences, Human Stem Cells Institute, Catalent Inc., OriGene Technologies Inc., Epeius Biotechnologies Corporation, Becton Dickinson and Company, Promega Corporation, and Uniqure NV. These market players implement organic and in-organic growth strategies to develop geographically, enlarge their product offerings, augment customer base, and acquire market share.

Global Gene Delivery Technologies Market: By Delivery Systems

  • Viral Gene Delivery Systems
  • Non-Viral Gene Delivery Systems
  • Combined Hybrid Delivery Systems

Global Gene Delivery Technologies Market: By Application

  • Oncology
  • Infectious Diseases
  • Pulmonary Disorders
  • Cardiovascular Disorders
  • Diabetes
  • Others

Global Gene Delivery Technologies Market: By Route of Administration

  • Oral
  • Injectable
  • Nasal
  • Others

Global Gene Delivery Technologies Market: Regional Segmentation Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

Frequently Asked Questions

What are the key factors driving global gene delivery technologies market expansion?

The global gene delivery technologies market is driven by key factors such as the rising prevalence of chronic diseases, the growing demand for targeted therapies and the rising technological advancements.

What will be the value of the gene delivery technologies market during 2021 - 2026?

The global demand for the gene delivery technologies market was estimated at approximately USD 2,610.8 Million in 2020 and is expected to generate revenue of around USD 4,400.7 Million by the end of 2026, growing at a CAGR of around 15.3% between 2021 and 2026.

Which region will make notable contributions towards global gene delivery technologies market revenue?

North America and Europe together is contributing for significant share of the market, owing to the increase in occurrence of chronic diseases in the United States and Europe and the technological development in drug delivery technologies in this region.

What are the key players leveraging gene delivery technologies market growth?

The foremost market players driving in the global market of gene delivery technologies cover Novartis International AG, Horizon Discovery Group Co., Amgen Inc., QIAGEN, Oxford BioMedia plc, SignaGen Laboratories, SIBIONO, Hoffmann-La Roche AG, Shanghai Sunway Biotech Co. Ltd., Vectalys, Pfizer Inc., Sirion-Biotech GmbH, Bayer AG, Takara Bio Inc., Johnson & Johnson Services Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., System Biosciences, Human Stem Cells Institute, Catalent Inc., OriGene Technologies Inc., Epeius Biotechnologies Corporation, Becton Dickinson and Company, Promega Corporation, and Uniqure NV.

Table Of Content

  • Chapter 1 Executive Summary
    • 1.1. Introduction of Gene Delivery Technulogies
    • 1.2. Global Gene Delivery Technulogies Market, 2020 & 2026 (USD Million)
    • 1.3. Global Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 1.4. Global Gene Delivery Technulogies MarketAbsulute Revenue Opportunity, 2016 – 2026(USD Million)
    • 1.5. Global Gene Delivery Technulogies MarketIncremental Revenue Opportunity, 2020 – 2026(USD Million)
  • Chapter 2 Gene Delivery Technulogies Market – Delivery Systems Analysis
    • 2.1. Global Gene Delivery Technulogies Market – Delivery Systems Overview
    • 2.2. Global Gene Delivery Technulogies Market Share, by Delivery Systems, 2020 & 2026(USD Million)
    • 2.3. Viral Gene Delivery Systems
      • 2.3.1. Global Viral Gene Delivery Systems Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 2.4. Non-Viral Gene Delivery Systems
      • 2.4.1. Global Non-Viral Gene Delivery Systems Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 2.5. Combined Hybrid Delivery Systems
      • 2.5.1. Global Combined Hybrid Delivery Systems Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
  • Chapter 3 Gene Delivery Technulogies Market – Application Analysis
    • 3.1. Global Gene Delivery Technulogies Market – Application Overview
    • 3.2. Global Gene Delivery Technulogies Market Share, by Application, 2020 & 2026(USD Million)
    • 3.3. Onculogy
      • 3.3.1. Global Onculogy Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 3.4. Infectious Diseases
      • 3.4.1. Global Infectious Diseases Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 3.5. Pulmonary Disorders
      • 3.5.1. Global Pulmonary Disorders Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 3.6. Cardiovascular Disorders
      • 3.6.1. Global Cardiovascular Disorders Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 3.7. Diabetes
      • 3.7.1. Global Diabetes Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 3.8. Others
      • 3.8.1. Global Others Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
  • Chapter 4 Gene Delivery Technulogies Market – Route of Administration Analysis
    • 4.1. Global Gene Delivery Technulogies Market – Route of Administration Overview
    • 4.2. Global Gene Delivery Technulogies Market Share, by Route of Administration, 2020 & 2026(USD Million)
    • 4.3. Oral
      • 4.3.1. Global Oral Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 4.4. Injectable
      • 4.4.1. Global Injectable Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 4.5. Nasal
      • 4.5.1. Global Nasal Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 4.6. Others
      • 4.6.1. Global Others Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
  • Chapter 5 Gene Delivery Technulogies Market – Regional Analysis
    • 5.1. Global Gene Delivery Technulogies Market Regional Overview
    • 5.2. Global Gene Delivery Technulogies Market Share, by Region, 2020 & 2026(USD Million)
    • 5.3. North America
      • 5.3.1. North America Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
        • 5.3.1.1. North America Gene Delivery Technulogies Market, by Country, 2016 - 2026(USD Million)
      • 5.3.2. North America Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026
        • 5.3.2.1. North America Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026(USD Million)
      • 5.3.3. North America Gene Delivery Technulogies Market, by Application, 2016 – 2026
        • 5.3.3.1. North America Gene Delivery Technulogies Market, by Application, 2016 – 2026(USD Million)
      • 5.3.4. North America Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026
        • 5.3.4.1. North America Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026(USD Million)
      • 5.3.5. U.S.
        • 5.3.5.1. U.S. Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.3.6. Canada
        • 5.3.6.1. Canada Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 5.4. Europe
      • 5.4.1. Europe Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
        • 5.4.1.1. Europe Gene Delivery Technulogies Market, by Country, 2016 - 2026(USD Million)
      • 5.4.2. Europe Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026
        • 5.4.2.1. Europe Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026(USD Million)
      • 5.4.3. Europe Gene Delivery Technulogies Market, by Application, 2016 – 2026
        • 5.4.3.1. Europe Gene Delivery Technulogies Market, by Application, 2016 – 2026(USD Million)
      • 5.4.4. Europe Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026
        • 5.4.4.1. Europe Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026(USD Million)
      • 5.4.5. Germany
        • 5.4.5.1. Germany Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.4.6. France
        • 5.4.6.1. France Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.4.7. U.K.
        • 5.4.7.1. U.K. Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.4.8. Italy
        • 5.4.8.1. Italy Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.4.9. Spain
        • 5.4.9.1. Spain Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.4.10. Rest of Europe
        • 5.4.10.1. Rest of Europe Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 5.5. Asia Pacific
      • 5.5.1. Asia Pacific Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
        • 5.5.1.1. Asia Pacific Gene Delivery Technulogies Market, by Country, 2016 - 2026(USD Million)
      • 5.5.2. Asia Pacific Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026
        • 5.5.2.1. Asia Pacific Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026(USD Million)
      • 5.5.3. Asia Pacific Gene Delivery Technulogies Market, by Application, 2016 – 2026
        • 5.5.3.1. Asia Pacific Gene Delivery Technulogies Market, by Application, 2016 – 2026(USD Million)
      • 5.5.4. Asia Pacific Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026
        • 5.5.4.1. Asia Pacific Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026(USD Million)
      • 5.5.5. China
        • 5.5.5.1. China Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.5.6. Japan
        • 5.5.6.1. Japan Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.5.7. India
        • 5.5.7.1. India Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.5.8. South Korea
        • 5.5.8.1. South Korea Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.5.9. South-East Asia
        • 5.5.9.1. South-East Asia Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.5.10. Rest of Asia Pacific
        • 5.5.10.1. Rest of Asia Pacific Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 5.6. Latin America
      • 5.6.1. Latin America Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
        • 5.6.1.1. Latin America Gene Delivery Technulogies Market, by Country, 2016 - 2026(USD Million)
      • 5.6.2. Latin America Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026
        • 5.6.2.1. Latin America Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026(USD Million)
      • 5.6.3. Latin America Gene Delivery Technulogies Market, by Application, 2016 – 2026
        • 5.6.3.1. Latin America Gene Delivery Technulogies Market, by Application, 2016 – 2026(USD Million)
      • 5.6.4. Latin America Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026
        • 5.6.4.1. Latin America Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026(USD Million)
      • 5.6.5. Brazil
        • 5.6.5.1. Brazil Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.6.6. Mexico
        • 5.6.6.1. Mexico Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.6.7. Rest of Latin America
        • 5.6.7.1. Rest of Latin America Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
    • 5.7. The Middle-East and Africa
      • 5.7.1. The Middle-East and Africa Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
        • 5.7.1.1. The Middle-East and Africa Gene Delivery Technulogies Market, by Country, 2016 - 2026(USD Million)
      • 5.7.2. The Middle-East and Africa Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026
        • 5.7.2.1. The Middle-East and Africa Gene Delivery Technulogies Market, by Delivery Systems, 2016 – 2026(USD Million)
      • 5.7.3. The Middle-East and Africa Gene Delivery Technulogies Market, by Application, 2016 – 2026
        • 5.7.3.1. The Middle-East and Africa Gene Delivery Technulogies Market, by Application, 2016 – 2026(USD Million)
      • 5.7.4. The Middle-East and Africa Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026
        • 5.7.4.1. The Middle-East and Africa Gene Delivery Technulogies Market, by Route of Administration, 2016 – 2026(USD Million)
      • 5.7.5. GCC Countries
        • 5.7.5.1. GCC Countries Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.7.6. South Africa
        • 5.7.6.1. South Africa Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
      • 5.7.7. Rest of Middle-East Africa
        • 5.7.7.1. Rest of Middle-East Africa Gene Delivery Technulogies Market, 2016 – 2026(USD Million)
  • Chapter 6 Gene Delivery Technulogies Market – Competitive Landscape
    • 6.1. Competitor Market Share – Revenue
    • 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    • 6.3. Strategic Developments
      • 6.3.1. Acquisitions and Mergers
      • 6.3.2. New Products
      • 6.3.3. Research & Development Activities
  • Chapter 7 Company Profiles
    • 7.1. Novartis International AG
      • 7.1.1. Company Overview
      • 7.1.2. Product/ServicePortfulio
      • 7.1.3. Novartis International AG Sales, Revenue, and Gross Margin
      • 7.1.4. Novartis International AG Revenue and Growth Rate
      • 7.1.5. Novartis International AG Market Share
      • 7.1.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.2. Horizon Discovery Group Co.
      • 7.2.1. Company Overview
      • 7.2.2. Product/ServicePortfulio
      • 7.2.3. Horizon Discovery Group Co. Sales, Revenue, and Gross Margin
      • 7.2.4. Horizon Discovery Group Co. Revenue and Growth Rate
      • 7.2.5. Horizon Discovery Group Co. Market Share
      • 7.2.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.3. Amgen Inc.
      • 7.3.1. Company Overview
      • 7.3.2. Product/ServicePortfulio
      • 7.3.3. Amgen Inc. Sales, Revenue, and Gross Margin
      • 7.3.4. Amgen Inc. Revenue and Growth Rate
      • 7.3.5. Amgen Inc. Market Share
      • 7.3.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.4. QIAGEN
      • 7.4.1. Company Overview
      • 7.4.2. Product/ServicePortfulio
      • 7.4.3. QIAGEN Sales, Revenue, and Gross Margin
      • 7.4.4. QIAGEN Revenue and Growth Rate
      • 7.4.5. QIAGEN Market Share
      • 7.4.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.5. Oxford BioMedia plc
      • 7.5.1. Company Overview
      • 7.5.2. Product/ServicePortfulio
      • 7.5.3. Oxford BioMedia plc Sales, Revenue, and Gross Margin
      • 7.5.4. Oxford BioMedia plc Revenue and Growth Rate
      • 7.5.5. Oxford BioMedia plc Market Share
      • 7.5.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.6. SignaGen Laboratories
      • 7.6.1. Company Overview
      • 7.6.2. Product/ServicePortfulio
      • 7.6.3. SignaGen Laboratories Sales, Revenue, and Gross Margin
      • 7.6.4. SignaGen Laboratories Revenue and Growth Rate
      • 7.6.5. SignaGen Laboratories Market Share
      • 7.6.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.7. SIBIONO
      • 7.7.1. Company Overview
      • 7.7.2. Product/ServicePortfulio
      • 7.7.3. SIBIONO Sales, Revenue, and Gross Margin
      • 7.7.4. SIBIONO Revenue and Growth Rate
      • 7.7.5. SIBIONO Market Share
      • 7.7.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.8. Hoffmann-La Roche AG
      • 7.8.1. Company Overview
      • 7.8.2. Product/ServicePortfulio
      • 7.8.3. Hoffmann-La Roche AG Sales, Revenue, and Gross Margin
      • 7.8.4. Hoffmann-La Roche AG Revenue and Growth Rate
      • 7.8.5. Hoffmann-La Roche AG Market Share
      • 7.8.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.9. Shanghai Sunway Biotech Co. Ltd.
      • 7.9.1. Company Overview
      • 7.9.2. Product/ServicePortfulio
      • 7.9.3. Shanghai Sunway Biotech Co. Ltd. Sales, Revenue, and Gross Margin
      • 7.9.4. Shanghai Sunway Biotech Co. Ltd. Revenue and Growth Rate
      • 7.9.5. Shanghai Sunway Biotech Co. Ltd. Market Share
      • 7.9.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.10. Vectalys
      • 7.10.1. Company Overview
      • 7.10.2. Product/ServicePortfulio
      • 7.10.3. Vectalys Sales, Revenue, and Gross Margin
      • 7.10.4. Vectalys Revenue and Growth Rate
      • 7.10.5. Vectalys Market Share
      • 7.10.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.11. Pfizer Inc.
      • 7.11.1. Company Overview
      • 7.11.2. Product/ServicePortfulio
      • 7.11.3. Pfizer Inc. Sales, Revenue, and Gross Margin
      • 7.11.4. Pfizer Inc. Revenue and Growth Rate
      • 7.11.5. Pfizer Inc. Market Share
      • 7.11.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.12. Sirion-Biotech GmbH
      • 7.12.1. Company Overview
      • 7.12.2. Product/ServicePortfulio
      • 7.12.3. Sirion-Biotech GmbH Sales, Revenue, and Gross Margin
      • 7.12.4. Sirion-Biotech GmbH Revenue and Growth Rate
      • 7.12.5. Sirion-Biotech GmbH Market Share
      • 7.12.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.13. Bayer AG
      • 7.13.1. Company Overview
      • 7.13.2. Product/ServicePortfulio
      • 7.13.3. Bayer AG Sales, Revenue, and Gross Margin
      • 7.13.4. Bayer AG Revenue and Growth Rate
      • 7.13.5. Bayer AG Market Share
      • 7.13.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.14. Takara Bio Inc.
      • 7.14.1. Company Overview
      • 7.14.2. Product/ServicePortfulio
      • 7.14.3. Takara Bio Inc. Sales, Revenue, and Gross Margin
      • 7.14.4. Takara Bio Inc. Revenue and Growth Rate
      • 7.14.5. Takara Bio Inc. Market Share
      • 7.14.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.15. Johnson & Johnson Services Inc.
      • 7.15.1. Company Overview
      • 7.15.2. Product/ServicePortfulio
      • 7.15.3. Johnson & Johnson Services Inc. Sales, Revenue, and Gross Margin
      • 7.15.4. Johnson & Johnson Services Inc. Revenue and Growth Rate
      • 7.15.5. Johnson & Johnson Services Inc. Market Share
      • 7.15.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.16. Thermo Fisher Scientific Inc.
      • 7.16.1. Company Overview
      • 7.16.2. Product/ServicePortfulio
      • 7.16.3. Thermo Fisher Scientific Inc. Sales, Revenue, and Gross Margin
      • 7.16.4. Thermo Fisher Scientific Inc. Revenue and Growth Rate
      • 7.16.5. Thermo Fisher Scientific Inc. Market Share
      • 7.16.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.17. Bio-Rad Laboratories Inc.
      • 7.17.1. Company Overview
      • 7.17.2. Product/ServicePortfulio
      • 7.17.3. Bio-Rad Laboratories Inc. Sales, Revenue, and Gross Margin
      • 7.17.4. Bio-Rad Laboratories Inc. Revenue and Growth Rate
      • 7.17.5. Bio-Rad Laboratories Inc. Market Share
      • 7.17.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.18. System Biosciences
      • 7.18.1. Company Overview
      • 7.18.2. Product/ServicePortfulio
      • 7.18.3. System Biosciences Sales, Revenue, and Gross Margin
      • 7.18.4. System Biosciences Revenue and Growth Rate
      • 7.18.5. System Biosciences Market Share
      • 7.18.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.19. Human Stem Cells Institute
      • 7.19.1. Company Overview
      • 7.19.2. Product/ServicePortfulio
      • 7.19.3. Human Stem Cells Institute Sales, Revenue, and Gross Margin
      • 7.19.4. Human Stem Cells Institute Revenue and Growth Rate
      • 7.19.5. Human Stem Cells Institute Market Share
      • 7.19.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.20. Catalent Inc.
      • 7.20.1. Company Overview
      • 7.20.2. Product/ServicePortfulio
      • 7.20.3. Catalent Inc. Sales, Revenue, and Gross Margin
      • 7.20.4. Catalent Inc. Revenue and Growth Rate
      • 7.20.5. Catalent Inc. Market Share
      • 7.20.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.21. OriGene Technulogies Inc.
      • 7.21.1. Company Overview
      • 7.21.2. Product/ServicePortfulio
      • 7.21.3. OriGene Technulogies Inc. Sales, Revenue, and Gross Margin
      • 7.21.4. OriGene Technulogies Inc. Revenue and Growth Rate
      • 7.21.5. OriGene Technulogies Inc. Market Share
      • 7.21.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.22. Epeius Biotechnulogies Corporation
      • 7.22.1. Company Overview
      • 7.22.2. Product/ServicePortfulio
      • 7.22.3. Epeius Biotechnulogies Corporation Sales, Revenue, and Gross Margin
      • 7.22.4. Epeius Biotechnulogies Corporation Revenue and Growth Rate
      • 7.22.5. Epeius Biotechnulogies Corporation Market Share
      • 7.22.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.23. Becton Dickinson and Company
      • 7.23.1. Company Overview
      • 7.23.2. Product/ServicePortfulio
      • 7.23.3. Becton Dickinson and Company Sales, Revenue, and Gross Margin
      • 7.23.4. Becton Dickinson and Company Revenue and Growth Rate
      • 7.23.5. Becton Dickinson and Company Market Share
      • 7.23.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.24. Promega Corporation
      • 7.24.1. Company Overview
      • 7.24.2. Product/ServicePortfulio
      • 7.24.3. Promega Corporation Sales, Revenue, and Gross Margin
      • 7.24.4. Promega Corporation Revenue and Growth Rate
      • 7.24.5. Promega Corporation Market Share
      • 7.24.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.25. Uniqure NV
      • 7.25.1. Company Overview
      • 7.25.2. Product/ServicePortfulio
      • 7.25.3. Uniqure NV Sales, Revenue, and Gross Margin
      • 7.25.4. Uniqure NV Revenue and Growth Rate
      • 7.25.5. Uniqure NV Market Share
      • 7.25.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
  • Chapter 8 Gene Delivery Technulogies — Industry Analysis
    • 8.1. Introduction and Taxonomy
    • 8.2. Gene Delivery Technulogies Market – Key Trends
      • 8.2.1. Market Drivers
      • 8.2.2. Market Restraints
      • 8.2.3. Market Opportunities
    • 8.3. Value Chain Analysis
    • 8.4. Key Mandates and Regulations
    • 8.5. Technulogy Roadmap and Timeline
    • 8.6. Gene Delivery Technulogies Market – Attractiveness Analysis
      • 8.6.1. By Delivery Systems
      • 8.6.2. By Application
      • 8.6.3. By Route of Administration
      • 8.6.4. By Region
  • Chapter 9 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    • 9.1. Gene Delivery Technulogies Industrial Chain Analysis
    • 9.2. Downstream Buyers
    • 9.3. Distributors/Traders List
  • Chapter 10 Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter 11 Report Conclusion& Key Insights
    • 11.1. Key Insights from Primary Interviews & Surveys Respondents
    • 11.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  • Chapter 12 Research Approach & Methodulogy
    • 12.1. Report Description
    • 12.2. Research Scope
    • 12.3. Research Methodulogy
      • 12.3.1. Secondary Research
      • 12.3.2. Primary Research
      • 12.3.3. Statistical Models
        • 12.3.3.1. Company Share Analysis Model
        • 12.3.3.2. Revenue Based Modeling
      • 12.3.4. Research Limitations

Inquiry For Buying

Gene Delivery Technologies

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Gene Delivery Technologies

Please fill out the form. We will contact you within 24 hours:
All fields required...
Inquiry For Buying

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com